Login / Signup

Lipoxin A4 Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis via Promoting the Regression of Inflammation.

Feng HuZilu QuKai ChenPing ZhangBei WangRuili JiangYuyue ZuoPing XiaHongxiang Chen
Published in: Clinical, cosmetic and investigational dermatology (2023)
LXA4 significantly ameliorates IMQ-induced psoriasis-like inflammation, and LXA4 can be used as a target for psoriasis treatment.
Keyphrases
  • oxidative stress
  • diabetic rats
  • high glucose
  • atopic dermatitis
  • mouse model
  • drug induced
  • endothelial cells
  • combination therapy
  • smoking cessation